MO30-1 Factors critical for the acquisition of antibody after SARS-CoV-2 vaccination in malignant lymphoma patients

Detalles Bibliográficos
Autores principales: Okamoto, Akinao, Hidetsugu, Fujigaki, Chisako, Iriyama, Naoe, Goto, Hideyuki, Yamamoto, Keichiro, Mihara, Yoko, Inaguma, Yasuo, Miura, Katsuya, Furukawa, Yukiya, Yamamoto, Yoshiki, Akatsuka, Senji, Kasahara, Kotaro, Miyao, Okamoto, Masataka, Saito, Kuniaki, Tomita, Akihiho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300380/
http://dx.doi.org/10.1016/j.annonc.2022.05.179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300380/
http://dx.doi.org/10.1016/j.annonc.2022.05.179

Ejemplares similares